Oric Pharmaceuticals Stock Performance

ORIC Stock  USD 10.26  0.50  4.65%   
The company holds a Beta of 0.86, which implies possible diversification benefits within a given portfolio. Oric Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Oric Pharmaceuticals is expected to follow. At this point, Oric Pharmaceuticals has a negative expected return of -0.27%. Please make sure to check Oric Pharmaceuticals' treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Oric Pharmaceuticals performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more

Actual Historical Performance (%)

One Day Return
(4.65)
Five Day Return
(12.31)
Year To Date Return
25.58
Ten Year Return
(60.19)
All Time Return
(60.19)
1
Oric Pharmaceuticals Upgraded to Buy Heres What You Should Know
11/18/2025
2
Disposition of 5534 shares by Kunkel Lori Anne of Oric Pharmaceuticals at 3.75 subject to Rule 16b-3
12/04/2025
3
ORIC Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025
12/05/2025
4
Disposition of 22000 shares by Chacko Jacob of Oric Pharmaceuticals subject to Rule 16b-3
12/15/2025
5
ORIC Pharmaceuticals Surges as Intriguing ESMO Asia Data for Enozertinib Prompts Wells Fargo to Assign Higher Value
12/16/2025
6
Oric Pharmaceuticals CEO Sells 33,374 Shares
12/18/2025
7
Companies Like ORIC Pharmaceuticals Are In A Position To Invest In Growth -
12/23/2025
8
Acquisition by Chacko Jacob of 112500 shares of Oric Pharmaceuticals subject to Rule 16b-3
01/02/2026
9
ORIC Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
01/06/2026
10
Oric Pharmaceuticals Shares Gap Up After Analyst Upgrade
01/09/2026
11
Oric Pharmaceuticals Sees Large Volume Increase - Still a Buy - MarketBeat
01/14/2026
12
Assessing ORIC Pharmaceuticals Valuation After Fresh Buy Ratings And Johnson Johnson Collaboration
01/16/2026
13
Short Interest in Oric Pharmaceuticals, Inc. Increases By 19.6
01/20/2026
14
Brokerages Set Oric Pharmaceuticals, Inc. PT at 19.90
01/29/2026
Begin Period Cash Flow23.9 M
Total Cashflows From Investing Activities22.1 M

Oric Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  1,269  in Oric Pharmaceuticals on November 2, 2025 and sell it today you would lose (243.00) from holding Oric Pharmaceuticals or give up 19.15% of portfolio value over 90 days. Oric Pharmaceuticals is currently does not generate positive expected returns and assumes 3.8583% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Oric, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 5.2 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Oric Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Oric Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 10.26 90 days 10.26 
about 61.66
Based on a normal probability distribution, the odds of Oric Pharmaceuticals to move above the current price in 90 days from now is about 61.66 (This Oric Pharmaceuticals probability density function shows the probability of Oric Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Oric Pharmaceuticals has a beta of 0.86. This indicates Oric Pharmaceuticals market returns are highly-sensitive to returns on the market. As the market goes up or down, Oric Pharmaceuticals is expected to follow. Additionally Oric Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Oric Pharmaceuticals Price Density   
       Price  

Predictive Modules for Oric Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oric Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.3710.2614.15
Details
Intrinsic
Valuation
LowRealHigh
6.4710.3614.25
Details
Naive
Forecast
LowNextHigh
4.668.5512.44
Details
12 Analysts
Consensus
LowTargetHigh
19.1121.0023.31
Details

Oric Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Oric Pharmaceuticals is not an exception. The market had few large corrections towards the Oric Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oric Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oric Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.37
β
Beta against Dow Jones0.86
σ
Overall volatility
1.72
Ir
Information ratio -0.1

Oric Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oric Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oric Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Oric Pharmaceuticals generated a negative expected return over the last 90 days
Oric Pharmaceuticals has high historical volatility and very poor performance
Oric Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (127.85 M) with profit before overhead, payroll, taxes, and interest of 0.
Oric Pharmaceuticals currently holds about 227.06 M in cash with (112.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74.
Over 93.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Brokerages Set Oric Pharmaceuticals, Inc. PT at 19.90

Oric Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oric Stock often depends not only on the future outlook of the current and potential Oric Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oric Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding69.7 M
Cash And Short Term Investments256 M

Oric Pharmaceuticals Fundamentals Growth

Oric Stock prices reflect investors' perceptions of the future prospects and financial health of Oric Pharmaceuticals, and Oric Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oric Stock performance.

About Oric Pharmaceuticals Performance

By analyzing Oric Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Oric Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Oric Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Oric Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.42)(0.44)
Return On Capital Employed(0.52)(0.54)
Return On Assets(0.42)(0.44)
Return On Equity(0.60)(0.63)

Things to note about Oric Pharmaceuticals performance evaluation

Checking the ongoing alerts about Oric Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Oric Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Oric Pharmaceuticals generated a negative expected return over the last 90 days
Oric Pharmaceuticals has high historical volatility and very poor performance
Oric Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (127.85 M) with profit before overhead, payroll, taxes, and interest of 0.
Oric Pharmaceuticals currently holds about 227.06 M in cash with (112.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74.
Over 93.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Brokerages Set Oric Pharmaceuticals, Inc. PT at 19.90
Evaluating Oric Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Oric Pharmaceuticals' stock performance include:
  • Analyzing Oric Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oric Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Oric Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Oric Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oric Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Oric Pharmaceuticals' stock. These opinions can provide insight into Oric Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Oric Pharmaceuticals' stock performance is not an exact science, and many factors can impact Oric Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Oric Stock analysis

When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges